Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Co-Diagnostics, Inc. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
CODX
Nasdaq
3840
co-dx.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Co-Diagnostics, Inc.
Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference
- May 14th, 2025 7:30 am
Co-Diagnostics Inc (CODX) Q1 2025 Earnings Call Highlights: Strategic Advancements Amid Revenue ...
- May 9th, 2025 1:41 am
Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results
- May 8th, 2025 2:01 pm
Concentra Group (CON) Tops Q1 Earnings and Revenue Estimates
- May 7th, 2025 5:35 pm
Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast
- Apr 29th, 2025 5:30 am
All You Need to Know About CoDiagnostics (CODX) Rating Upgrade to Buy
- Apr 2nd, 2025 10:00 am
Co-Diagnostics Full Year 2024 Earnings: Misses Expectations
- Mar 29th, 2025 7:18 am
Co-Diagnostics Inc (CODX) Q4 2024 Earnings Call Highlights: Navigating Challenges with ...
- Mar 28th, 2025 1:03 am
Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results
- Mar 27th, 2025 2:01 pm
Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast
- Mar 13th, 2025 7:30 am
The Beauty Health Company (SKIN) Reports Q4 Loss, Tops Revenue Estimates
- Mar 12th, 2025 3:25 pm
Co-Diagnostics, Inc. Wins Dismissal of Class Action Lawsuit
- Mar 6th, 2025 1:30 pm
Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025
- Mar 3rd, 2025 7:30 am
Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version
- Feb 24th, 2025 6:18 am
Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance
- Feb 21st, 2025 2:00 pm
Co-Diagnostics, Inc. to Exhibit at BioUtah's 2025 Life Sciences Day on the Hill
- Jan 30th, 2025 7:30 am
Co-Diagnostics, Inc. to Participate at the Nasdaq Live from MarketSite Broadcast at Silicon Slopes 2025
- Jan 7th, 2025 7:30 am
Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility
- Dec 10th, 2024 7:30 am
Co-Diagnostics Third Quarter 2024 Earnings: Beats Expectations
- Nov 10th, 2024 5:30 am
Co-Diagnostics Inc (CODX) Q3 2024 Earnings Call Highlights: Navigating Revenue Decline and ...
- Nov 8th, 2024 8:03 am
Scroll